风湿性多肌痛

肿瘤坏死因子抑制剂

欧洲抗风湿病联盟 (European League Against Rheumatism)/美国风湿病学会 (American College of Rheumatology) 指南强烈建议不要使用肿瘤坏死因子抑制剂，理由是疗效证据缺乏、潜在的不良反应增加以及成本高昂。[38]Dejaco C, Singh YP, Perel P, et al; European League Against Rheumatism; American College of Rheumatology. 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheumatol. 2015;67:2569-2580.http://onlinelibrary.wiley.com/doi/10.1002/art.39333/fullhttp://www.ncbi.nlm.nih.gov/pubmed/26352874?tool=bestpractice.com

羟氯喹

非常有限的数据显示羟氯喹对接受皮质类固醇治疗出现不良反应的患者有益；但是这并非标准治疗方法。